Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
By J. Sarmiento, G. Heywood, J. Rubin, D. Ilstrup, D. Nagorney, F. Que. Journal of the American College of Surgeons, 2003
779 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/ffd6d70a81413f7246aef912e186d58e1eddded6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Bilimoria
- C. Ko
- C. Bennett
- J. Wayne
- D. Bentrem
- M. Talamonti
Citations in the corpus
- Small Bowel Cancer in the United States: Changes in Epidemiology, Treatment, and Survival Over the Last 20 Years (2009, background): “Patients with carcinoid tumors and synchronous liver metastases are often considered to be candidates for resection as debulking is associated with extended survival.(33,34) In a previous population-based study, we found this to be true for pancreatic neuroendocrine tumors(12); however, in the curre”